Israel Valero-Lopez
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial.
Journal: Cancers
Published: April 07, 2022
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Journal: Autophagy
Published: February 26, 2021
Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
Journal: Theranostics
Published: October 23, 2019
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
Journal: Biochemical pharmacology
Published: June 25, 2018
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
Journal: Biochemical pharmacology
Published: June 21, 2018
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
Journal: The Journal of investigative dermatology
Published: November 05, 2014
TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling.
Journal: Molecular & cellular oncology
Published: October 13, 2014
Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation.
Journal: Cell death and differentiation
Published: February 06, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026